Nothing Special   »   [go: up one dir, main page]

CN1232651C - Clinical biochip for detecting bacteria - Google Patents

Clinical biochip for detecting bacteria Download PDF

Info

Publication number
CN1232651C
CN1232651C CN 03100675 CN03100675A CN1232651C CN 1232651 C CN1232651 C CN 1232651C CN 03100675 CN03100675 CN 03100675 CN 03100675 A CN03100675 A CN 03100675A CN 1232651 C CN1232651 C CN 1232651C
Authority
CN
China
Prior art keywords
biochip
same
probes
bacterium
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 03100675
Other languages
Chinese (zh)
Other versions
CN1519328A (en
Inventor
翟俊辉
杨瑞馥
宋亚军
郭兆彪
王津
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Microbiology and Epidemiology of AMMS
Original Assignee
Institute of Microbiology and Epidemiology of AMMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Microbiology and Epidemiology of AMMS filed Critical Institute of Microbiology and Epidemiology of AMMS
Priority to CN 03100675 priority Critical patent/CN1232651C/en
Publication of CN1519328A publication Critical patent/CN1519328A/en
Application granted granted Critical
Publication of CN1232651C publication Critical patent/CN1232651C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention discloses a biological chip which is characterized in that a GenBank data base is used in the design of combination probes of the chip to search ribosome nucleic acid gene sequences of 50 to 100 kinds of bacteria. Software, such as Primer Premiere, DNAStar, Clustal-X, etc., is used for designing primers and probes, comparing the sequences and conventionally synthesizing all related oligonucleotide sequences, and each kind of bacterium is provided with four probes. The synthesized probes are dissolved by 40% to 60% of DMSO, and the final concentration is 1 g/l to 3 g/l. The biological chip is arranged in a GSI Flexys sample applicator for setting a sample procedure into a point embattling type. The present invention has the advantages of specificity accuracy, high speed and sensitivity and embodies one-to-many detecting modes.

Description

A kind of biochip that is used for the clinical bacteria detection
Technical field
The present invention relates to a kind of biochip, particularly relate to a kind of biochip that clinical bacteria detects that is used for.
Background technology
Although viral infection such as acquired immune deficiency syndrome (AIDS), hepatitis and hemorrhagic fever etc. become worse, infectation of bacteria remains one of human health and threatens greatly.For example the death toll that causes of tuberculosis still occupies the No. 1 in the world, and the sign that stages a comeback is arranged; The streptococcal infection of B family is fatal often with interior newborn infant for two months; The Salmonellas of food source, listeria spp and intestinal bacteria etc. are the important factors that causes diarrhoea; The air conditioner ventilating system of large-scale totally-enclosed building is often breeding legionella pneumophilia, a kind of pathogenic bacteria of legionnaires disease; Cause that several cause of diseases of pneumonia such as Klebsiella pneumonia, pneumococcus, Chlamydia pneumoniae, Mycoplasma pneumoniae etc. often constitute very big threat to lower for the resistance, old or young crowd; Charrin disease is a modal infection type among burn, the war wound patient, and difficult with control; Hemophilus influenzae is the common bacteria in the upper respiratory tract infection, is difficult to separation and Culture; Infection of staphylococcus aureus is plain stubborn, and resistance is very general; Meningococcus threatens bigger to the still very imperfect children of resistibility.The diagnosis of bacterial infection and detection have important directive significance for clinical treatment.Although various Broad spectrum antibiotics is arranged, so-called wide spectrum also has certain sphere of action, is not all effective to all clinical bacterias; And microbiotic abuse problem is more and more outstanding, uses the New-type wide-spectrum microbiotic to hide some dangers for for later antibiotic therapy simply, and when reusing such microbiotic, its effect just can not normally be brought into play again.
In case having established is the infection of any bacterium, just can take out treatment plan with strong points, infectation of bacteria will soon be effectively controlled.Therefore the detection of infectious bacteria kind has crucial clinical guidance meaning.The detection method of bacterium is varied, the primary goal of qualitative detection yes Clinical Laboratory; Detection by quantitative has more deep understanding for number of bacteria and gradient of infection.The method that has not only can be qualitative but also can be quantitative, as enzyme linked immunosorbent assay (ELISA, enzyme-linkedimmunosorbent assay), polymerase chain reaction (PCR, polymerase chain reaction) and nucleic acid hybridization etc.Every kind of Bacteria Detection means all have the relative merits of oneself, can not rely on single means to come bacterium is carried out qualitative, and any detection method all is a factor in the numerous methods of clinical conclusive evidence.There are two in classical way than obvious defects: the one, and detection time is generally longer, and the 2nd, belonging to man-to-man detecting pattern is that single test can only detect a kind of bacterium.
Summary of the invention
The object of the invention is to provide a kind of oligonucleotide combination probe micro-array biochip, can be used for the disposable detection of multiple pathogenetic bacteria, improves the accuracy and the reliability that detect, shortens the classical required time of detecting.
The present invention seeks to be achieved through the following technical solutions:
Biochip involved in the present invention be with bacterial 16 S ribosomal nucleic acid serve as the amplification target design.16S rrna nucleic acid extensively is present in these class prokaryotic organism of bacterium, for example all has the 16S ribosomal rna sequence in archeobacteria, eubacterium, rickettsia, mycoplasma, chlamydozoan, spirochete and the actinomycetes.Ribosomal rna sequence is alternately arranged by conserved sequence and variable sequence and is constituted, and we are located in the variable region by designed oligonucleotide combination probe.Selected rrna nucleic acid variable region variation specific sequence designing probe greatly, at 4 of every kind of bacterium designs, 4 characteristic variable regions of corresponding bacterial ribosome nucleic acid respectively.Use corresponding information biology software design and go out the probe of multiple pathogenetic bacteria, then probe and GenBank database are compared, tentatively determine the probe feasibility according to return message.Transferring to commercialization company after probe is determined, to carry out nucleotide sequence synthetic.Synthetic good probe uses GSI Flexys high-density point sample instrument to carry out point sample.
Concrete steps are as follows:
The design of 1 combination probe: utilize the GenBank database, the rrna nucleic acid gene sequence of retrieval various bacteria, number of bacteria can be decided according to the practical application needs, for example the 50-100 kind.Use Primer Premiere, DNAStar, softwares such as Clustal-X carry out primer, probe design and sequence relatively, conventional synthetic all oligonucleotide sequences that relate to.4 probes of every kind of bacterium design.
Serve as the amplification target with 16S rRNA in the combination probe of the present invention design, the universal amplification primer is S1:5 '-AGA GTT TGA TC (A/C) TGG CTC AG-3 ' and S2:5 '-CCG TCA ATT C (A/C) T TT (A/G) AGT TT-3 ', and the amplified fragments size is 890-bp-930-bp.
2 point samples: will synthesize good probe and dissolve with 40-60%DMSO, ultimate density is 1-3g/l.Biochip is placed GSI Flexys point sample instrument, the point sample program is set, the point sample of structuring the formation is as accompanying drawing point sample form.Make gene chip of the present invention.
The using method of gene chip of the present invention is, various clinical samples are comprised that blood, cerebrospinal fluid, ascites, phlegm, collutory, chest hydrops etc. extract nucleic acid after treatment, adopt the method for polymerase chain reaction (PCR) that fluorescein (Cy5-dCTP) is incorporated in the PCR product, the PCR product is added to through thermally denature and carries out hybridization on the biochip.Reacted chip uses chip scanner scanning, judges the kind of pathogenetic bacteria according to results of hybridization.
Biochip of the present invention utilizes nucleic acid amplification in vitro technology, and the specificity of bind nucleic acid hybridization can be finished detection time in 6 hours; And can easily hold hundreds and thousands of specific probes, single test can detect a plurality of targets, need not repetition, and therefore required sample size also has only portion.Use combination probe to improve the specificity that detects.Differentiate meaning although bacterial ribosome nucleic acid has certain kind, because its conservative property, its rrna nucleic acid of kind in very near source was quite similar on some was evolved.It is very difficult to adopt a probe to distinguish these nearly derived bacteriums separately, relies on the combination of 4 probes to come corresponding a kind of bacterium, has improved the accuracy that detects greatly.This has crucial meaning for overcoming cross reaction and the false positive results that ordinary method hybridization produced.
The related bacterium of the embodiment of the invention all is significant clinically pathogenic bacterium.The conventional sense means waste time and energy, and order of accuarcy is not high, and biochip of the present invention need not repetition and trial, thereby tool has an enormous advantage in Clinical Laboratory because primary first-order equation just can detect related bacterium.In addition, have the cause of disease that causes important transmissible disease, be the plague that rises year by year, the enteron aisle prevailing disease that generation is all arranged every year, bacterial food poisoning etc. as anthrax bacillus and Brucella, the outbreak of epidemic danger that causes the infecting both domestic animals and human disease in the pastoral area in China.For the diagnosis of these strong pathogenic agent, domestic also do not have simple and rapid diagnostic reagent commodity.Biochip of the present invention can be used for multinomial fields such as customs quarantine control, health and epidemic prevention, environmental monitoring, food inspection equally, thereby has huge market outlook.
The terrorist utilizes strong pathogenic agent to cause great threat for country and social safety as the bioterrorism event of bio-terrorism means manufacturing, and Biosafety and bio-terrorism defend to have become national governments and the country and the social safety major issue of numerous people common concern today.The strong pathogenic agent that rapid detection goes out in the bioterrorism event is most important to the harm of taking correct means elimination terrorist incident to cause, biochip of the present invention will help to improve the ability that we tackle the burst biological event, can calm down people's psychology fear, prevent to cause social unrest, guarantee social safety that the social agency of its generation is very huge with influence and effectively prevent and control bioterrorism event.Except that bioterrorism event, the eruption and prevalence of deadly infectious disease, tend to make a lot of people's infection even seize a lot of people's life, also can cause people huge psychological fear and social unrest, make diagnosis fast, the control disease of taking measures is popular can produce powerful social agency and influence equally.
Advantage of the present invention is embodied in:
Special accurate: as because the present invention has adopted combination probe, to point to a bacterium, therefore increased detection specificity greatly by many probes.
Fast: biochip test of the present invention comprises sample pre-treatments, pcr amplification and chip hybridization, about 6 hours consuming time altogether, conventional bacterium separation and Culture needs about 3 days, and clinical bacteria to be separated into power lower, some bacterium separation and Culture that What is more needs two weeks to month, as mycobacterium tuberculosis.The present invention can shorten Diagnostic Time.
Sensitive: biochip of the present invention combines the pcr amplification technology, therefore has higher sensitivity.
The one-to-many detecting pattern: all bacteriums in the single test testing goal sample, reduce sample size, reduced simultaneously because the expensive and time of repeatedly attempting bringing.Though nonrecurring cost is high relatively slightly, if consider detection when being tens kinds of bacteriums, its relative cost remains low-down.
Following experimental example is used to further specify the present invention.
Experimental example 1:The hybridization of pure cultures of bacteria
Cultivate 80 kinds of bacteriums according to pertinent literature.Use QIAGEN DNeasy Tissue Kit (Cat.No.69504) to extract bacterial chromosomal dna.Use the corresponding bacterial chromosomal dna of S1,10mM Tris-HCl (pH 8.4) with the S2 primer amplification; 50mM KCl; 1.5mM MgCl 2Gelatin 0.01%; TritonX-100 0.1%; Tween 20 0.01%; 40 μ M of dATP, dTTP and dGTP, 30 μ M ofdCTP (Promega), 10 μ M of Cy5-dCTP (Amersham Pharmacia Biotech), 0.1 μ M of each primer, 2U of Taq polymerase (worker's biotechnology company limited is given birth in Shanghai) and 15ng amplification template.The PCR parameter is 95 ℃ of pre-sex change, and 15min is 94 ℃ then, 10s; 63 ℃, 10s; 72 ℃, 15s; 29 circulations.Product uses Amicon Microcon-PCR colums, and (final elution volume is 25 μ l for Millipore, USA) purifying.Getting amplified production 10 μ l behind fluorescent mark and the purifying joins and forms the hybridization working fluid in the 90 μ l hybridization solutions, chip is put into GSI GeneTACHybridization Station hybridization instrument hybridizes, at 80 ℃ of adding probes, pre-sex change 10min, hybridization temperature is 45 ℃, hybridization time 1 hour.Take out biochip after finishing, use the scanning of GSI GeneTAC1000 biochip scanner, analysis and saving result.Utilize the results of hybridization of pure cultures of bacteria to show that biochip of the present invention can relate to major part Bacteria Identification to the position of planting.
Experimental example 2:Sensitivity test
With LB inclined-plane switching streptococcus aureus and Pseudomonas aeruginosa, cultivated 12 hours for 37 ℃.Scrape with transfering loop and to get one and encircle among the 5ml 0.03mol/L PBS, do 10 times of serial dilutions then until 10-9.Utilize dull and stereotyped streak method that two kinds of bacteriums are carried out enumeration.Get each extent of dilution and carry out the chip hybridization experiment, chip hybridization sensitivity behind the observation bacterium serial dilution.Get legionella pneumophilia chromosomal DNA 15ng/ml, 1.5ng/ml, 150pg/ml, 15pg/ml, 1.5pg/ml it is fluorescein-labelled that four extent of dilution carry out pcr amplification and Cy5 respectively, uses fluorescein-labelled thing and chip hybridization then, observes the hybridization sensitivity of karyomit(e) dilution back.Through plate count, calculate bacterium liquid original concentration.Streptococcus aureus is 2.35 * 10 7CFU/ml (colony forming unit), Pseudomonas aeruginosa is 2.0 * 10 7CFU/ml.For two kinds of bacterium liquid, biochip test sensitivity is 235 and 200CFU.And simulation blood specimen sensitivity, 150pg/ml karyomit(e) can be observed positive signal through PCR, though and 15pg/ml PCR has not observed band, biochip still can detect positive signal, highly sensitive 10 times than PCR-electrophoretic method of biochips.
Experimental example 3:The specificity test
Use Mycobacterium bovis, Mycobacterium intracellulare, mycobacterium avium and these several bacterial classifications close with mycobacterium tuberculosis of mycobacterium littorale to carry out chip hybridization, observation and mycobacterium tuberculosis intersect situation.Test-results shows, hybridizes with in the Mycobacterium bovis of the nearly edge of mycobacterium tuberculosis and Mycobacterium intracellulare and 4 probes of mycobacterium tuberculosis 3, and mycobacterium littorale and mycobacterium avium are only hybridized with 2 probes.That is to say that combination probe has played critical discriminating effect here, if do not use combination probe, the close bacterium of the so multiple class of very difficult differentiation.
Experimental example 4:Practical application
Biochip of the present invention has passed through simulation blood specimen and double-blind method test, proves that it has sizable reliability.The streptococcus aureus and the Pseudomonas aeruginosa bacterium liquid 20 μ l of serial dilution in the experimental example 2 are joined in the 180 μ l horse blood, form the simulation blood specimen of series concentration.Extract the test kit operation instructions according to the QIAamp whole blood DNA and extract DNA, and it is fluorescein-labelled to carry out Cy5 as template, carries out chip hybridization according to the method described above, observes simulation blood specimen hybridization sensitivity.Simulation blood specimen sensitivity is respectively 23500 and 2000CFU.
Get the chromosomal DNA of 3 unknown samples, label is 1,2 and 3.Carry out 1,2,3,1+2,1+3,2+3 and 1+2+3 combination, wherein built-up sequence and mode the unknown finished sample combination by an other people.This 8 duplicate samples (moisture) is simulated Blind Test, with the array mode contrast, judges the feasibility that various product detect then.Compound sample Blind Test experimental result shows, if exist more than one object to be measured also can detect simultaneously in the sample.Two kinds of bacterium mixing energies detect simultaneously, and three kinds of bacterium mix and generally can detect wherein dominant two kinds of bacterium simultaneously.If several bacterial concentrations in actual the infection are roughly consistent, then biochip can detect them simultaneously.
Experimental example 5:
Two parts of certain hospital's censorship samples, suspecting has Pseudomonas aeruginosa.Through after the biochip hybridization, find that 4 probes of a strain bacterium and Pseudomonas aeruginosa are hybridized, another strain bacterium then hybridizes with 4 probes of salmonella typhi.Thereby be judged to be Pseudomonas aeruginosa and salmonella typhi respectively.Find after the microbial culture that the former produces green pigment, and the latter does not have, this is consistent with the feature of Pseudomonas aeruginosa.Judgement with classical Bacteria Identification program and nucleic acid authentication method proof and biochip matches then.
Description of drawings:
Accompanying drawing 1 is a combined probe type biochip Pareto diagram, wherein the positive control point of point in the solid box.
Embodiment
Embodiment:
1, probe design: utilize the GenBank database, the rrna nucleic acid gene sequence of 80 kinds of bacteriums of retrieval, use Primer Premiere, DNAStar, softwares such as Clustal-X carry out primer, probe design and sequence relatively, and it is synthetic by the living worker's biotechnology in Shanghai company limited that all relate to the synthetic oligonucleotide sequence.16S rRNA universal amplification primer is S1:5 '-AGA GTT TGA TC (A/C) TGGCTC AG-3 ' and S2:5 '-CCG TCA ATT C (A/C) T TT (A/G) AGT TT-3 ', and the amplified fragments size is 890-bp-930-bp.80 kinds of bacteriums are designed 320 probes (seeing attached list 2) altogether.4 probes of every kind of bacterium design.
Point sample: will synthesize good probe and dissolve with an amount of 50%DMSO, ultimate density is 2g/l.Biochip places GSI Flexys point sample instrument, and the point sample program is set, and the point sample of structuring the formation is put to become as accompanying drawing sample form.Wherein the point sample corresponding relation of 80 kinds of bacteriums is as shown in table 1::
Table 1: built-up type oligonucleotide probe and accompanying drawing corresponding relation
The dog brucella The hot rickettsia of Q The pneumophila legionella pneumophilia The fluorescens Pseudomonas fluorescens The aureus streptococcus aureus
I Brucella melitenis alcaligenes melitensis Ehrlichia canis dog Ai Like body Listeria monocytogenes monocyte hyperplasia listeria spp Pseudomonas putida pseudomonas putida Staphylococcus epidemidis staphylococcus epidermidis
J Burkholderia cepacia onion bulkholderia cepasea Enterobacter aerogenes enteroaerogen Moraxella catarrhis morazella catarrhalis Pseudomonas stutzeri Pseudomonas stutzeri Stenotrophomonas maltophilia has a liking for the few food of Fructus Hordei Germinatus Zymomonas mobilis
K Burkholderia pseumonallei pseudoglanders bulkholderia cepasea Enterobacter cloacae enterobacter cloacae Mycobacterium avium mycobacterium avium Rickettsia prowazekii Rickettsia prowazeki Streptococcus agalactiae streptococcus agalactiae
L Chlamydia pneumoniae Chlamydia pneumoniae Enterococcus faecalis enterococcus faecalis Mycobacterium bovis Mycobacterium bovis The vertical rickettsia of Rickettsia rickettsia Streptococcus pneumoniae streptococcus pneumoniae
M Chlamydia psittaci chlamydia psittaci Enterococcus faecium faecium Mycobacterium intracellular Mycobacterium intracellulare Salmonella paratyphi salmonella paratyphi Streptococcus pyogenes streptococcus pyogenes
N Chlamydia trachomatis sand holes chlamydozoan Escherichia coli intestinal bacteria Mycobacterium smegmatis M. smegmatics Salmonella typhi salmonella typhi Streptococcus salivarium streptococcus-salivarius
O Citrobacter amalonaticus does not have the propanedioic acid citric acid bacillus The graceful pseudomonas fluorescens of the rich taste of Fluoribacter bozemanae Mycobacterium tuberculosis mycobacterium tuberculosis Salmonella typhimurium Salmonella typhimurium Yersinia enterocolitica yersinia entero-colitica
P Citrobacter freundii citrobacter freundii Francisella tularensis soil draws not Salmonella Mycobacterium xenopi mycobacterium littorale Serratia liquefaciens liquefied Serratia Yersinia pestis Yersinia pestis
Annotate: A1 to A4 represents 1 to No. 4 probe of E.coli, and A5 to A8 represents 1 to No. 4 probe of Citrobacter koseri, and the rest may be inferred by analogy.
Subordinate list 2:80 kind bacterial 16 S rRNA specific probe
Bacterial species 1 2 3 4
1.Acinetobacter calcoaceticus acinetobacter calcoaceticus CGGGGGAAGGTAGCTT GCTACCG CCTAGAGATAGTGGAC GTTAC GGGGAAGGGCAGCCAT CTGGC GGGCCTTTGAGGCTTTAG TGGCGC
2.Acinetobacter haemolyticus acinetobacter haemolyticus GTTGGGGCCTTTGAGG CTTTAGTG CTACTTTAGTTAATAC CTAGAGATA TCCTACGGGAGAAAGC AGGGGATC AGAGAGGTAGCTTGCTAC TGATCT
3.Bacillus anthracis Bacillus anthracis AAGTGTTAGAGGGTTT CCGCCCT AAGTGCTAGTTGAATA AGCTGGCAC AATTGAAAGGCGGCTT CGGCTGT GCGAATGGATTAAGAGCT TGCTCT
4.Bacteroides fragilis bacteroides fragilis TTTGCGATATACAGTA AGCGGCCA ATAAAGTGCAGTATGT ATACTGTTT TAATGATTCCGCATGG TTTCATTA AAGCTTGCTTTCTTTGCT GGCGA
5.Bartonella henselae Han Saiba entire body GGCGGTTTACTGCTCG GTGGCGCA ACCGGTGAAGATAATG ACGGTAACC CGTATACGTCCTATTT GGAGAAAG GCGCACTCTTTTAGAGTG AGCG
6.Bartonella quintana trench fever crust entire body GGGTGGTTTACTACTC GGTGGCG Same B.henselae TATACGTCCCTCTGGG AGAAAGA Same B.henselae
7.Brucella abortus Bacillus abortus CCGTCGGGGTGTTTAC ACTTCGG GGAGAAGATAATGACG GTAACCCGA ATGTGCTTGGGGGAAA GATTTATC CGAGCGCCCGCAAGGGTG AGCG
8.Brucella canis dog brucella B.abortus GGTGAAGATAATGACG GTAACCGGA GTGCCCTTCGGGGGAA AGATTTAT CGAGCGCCCCGCAAGGGG AGC
9.Brucella melitenis alcaligenes melitensis B.abortus Same B.canis Same B.canis Same B.canis
10.Burkholderia cepacia onion bulkholderia cepasea TTGTTGGGGATTCATT TCCTTAG AAATCCTTGGCTCTAA TACAGTCG CATACGATCTACGGAT GAAAGCG CACGGGTGCTTGCACCTG GTGG
11.Burkholderia Same B.cepacia AATCATTCTGGCTAAT ATACGATCTGAGGATG GCACGGGCTTCGGCCTGG
Pseumonallei pseudoglanders bulkholderia cepasea ACCCGGAGT AAAGCG TG
12.Chlamydia pneumoniae Chlamydia pneumoniae TTGATGTGGATGGTCT CAACCCCA AAGAGAGATTGGCTAA TATCCAAT TAATTAGGCATCTAAT ATATATTA GAATAATGACTTCGGTTG TTATTT
13.Chlamydia psittaci chlamydia psittaci CATACTTGATGTGGAT AGTCTCAA Same C.pneumoniae TTTAGGCATCTAAAAC ATATTAAA Same C.pneumoniae
14.Chlamydia trachomatis sand holes chlamydozoan Same C.pneumoniae GAAGACGGTTAATACC CGCTGGATT ATATTTGGGCATCCGA GTAACGTT AGCAATTGTTTCGACGAT TGTTT
15.Citrobacter amalonaticus does not have the propanedioic acid citric acid bacillus ATGTCTATTTGGAGGT TGTGCCCT AAGGGGTTAAGGTTAA TAACCTTAG ATAATGTCGCAAGACC AAAGAGGG TAACAGGAAGCAGCTTGC TGCTTT
16.Citrobacter freundii citrobacter freundii CGATGTCGACTTGGAG GTTGTGC AAGGCGTTGTGGTTAA TAACCGCAG Same C.amalonaticus TAGCACAGAGGAGCTTGC TCCTTG
17.Citrobacter the suitable citric acid bacillus of koseri Same C.freundii AAGGTGTTGTGGTTAA TAACCACAG Same C.amalonaticus Same C.amalonaticus
18.Clostridium botulinum Clostridium botulinum TAGGGGGTATCAACTC CCCCTGT The same ATTTTCTTATCAAAGA TTTATTGCTT The same
19.Clostridium perfringes clostridium perfringens GGGGTTTCAACACCTC CGTGCCG TCTGTCTTTGGGGAAG ATAATGACG CATCATCATTCAACCA AAGGAGCA ATGAAGTTTCCTTCGGGA AACG
20.Clostridium tetani clostridium tetani GGTGTAGGAGGGTCCA ACCTTCT TTTCTGGGACGATAAT GACGGTAC ACTTTAACCAAAGGAG TAATCTGCTT CGAGCGATGAAGCTTCCT TCGGGA
21.Corynebacterium TGAGGGTCTTCCACGA AAGCTTTTGTGACGGT TGTGGTGGAAAGTTTT AAAGGCCTAGCTTGCTAG
The diphtheriae diphtheria corynebacterium CTTTCGTG ACCTAGATA TCGGTACG GTACT
22.Corynebacterium pseudodiphtheriae corynebacterium diphtheroides TAGGGACCTTTTGGGG TTTCTGTG AAGCGTTTTGTGACGG TACCTGGAG GTGGAAAGTTTTTTCG GTGTAGGA GAAAGGCCTTCGGAGG TACTC
23.Corynebacterium xerosis Corynebacterium xerosis TAGGGGTCTTCCACGA CTTCTGT CATCGACGAAGGTTTT CTGACGGT CGCACCGTGAGGGTGT GGTGGAAA CCCCAGCTTCCTGGGGTA CACGA
24.Coxiella the hot rickettsia of burnetii Q TTGGGAAGTTCACTTC TTAGTAGC TTCTCAAGGGTAATAT CCTTGGGCG CATAATCTCTTTGGAG CAAAGCG GGAGCTTGCTCCTGGCGG CGAG
25.Ehrlichia canis dog Ai Like body TGAGGATTTTATCTTT GTATTGTA TAATGACGGTACCTAT AGAAGAAGT ACTGTATAATCCCCGA GGGGGAA CCTCTGGCTATAGGAAAT TGTT
26.Enterobacter aerogenes enteroaerogen Same K.pneumoniae GGCGTTAAGGTTAATA ACCTTGGCG TAACGTCGCAAGACCA AAGTGGG CACAGAGAGCTTGCTCTC GGGT
27.Enterobacter cloacae enterobacter cloacae Same K.pneumoniae GGTGTTGTGGTTAATA ACCGCAGCA Same E.aerogenes Same E.aerogenes
28.Enterococcus faecalis enterococcus faecalis TGGAGGGTTTCCGCCC TTCAGTGC GGACGTTAGTAACTGA ACGTCCCCT AGTTTATGCCGCATGG CATAAGAG TTCCTCCCGAGTGCTTGC ACTC
29.Enterococcus faecium faecium E.faecalis ATGAGAGTAACTGTTC ATCCCTTG TCGAAACCGCATGGTT TTGATTTG TTTTCCACCGGAGCTTGC TCCA
30.Escherichia coli intestinal bacteria Same K.pneumoniae GAGTAAAGTTAATACC TTTGCTCAT TCTTGCCATCGGATGT GCCCA GAAGAAGCTTGCTCTTTG CTGA
31.Fluoribacter the graceful pseudomonas fluorescens of the rich taste of bozemanae TTGGTGATGTGAAAAT CATTAG CAGTGGGGAGGAGGTT YGCTAGGT ATGTCTAAGGACGAAA GCTGGGGA AAGTCGAACGGCAGCATG ACCT
32.Francisella tularensis soil draws GAGTCGGTGTAAAGGC TCTAGTGG GCCTCAAGGTTAATAG CCTTGGGGA ATCTGTGGATTAAAGG TGGCTTTC TAACAGGTCTTAGGATGC TGAC
Salmonella not
33.Haemophilus influenzae hemophilus influenzae GGATTGGGCTTAGAGC T TTGATGTGTTAATAGT ACATCAAAT AGATGAAAGTGCGGGA CTGAGAGG AGCAGGAGAAAGCTTGCT TTCTT
34.Haemophilus parainfluenzae haemophilus parainfluenzae CTTTTAGCTTGGCGCC CGTAGC GCATTTAGTTTAATAG ACTAGGTGAT TGATCGGGAGATGAAA GTGTGGG AACATGAAGAAGCTTGCT TCTTT
35.Hafnia alvei honeycomb Ha Funiya bacterium Same K.pneumoniae AGGGAGTAAAGTTAAT ACCTTTGC CCTTAGGGCCTCTTGC CATCGGAT TAACAGGAAACAGCTTGC TGTTT
36.Helicobacter pylori helicobacter pylori GAGGGCTTAGTCTCTC CAGTAATG TTGTTAGAGAAGATAA TGACGGTAT GATACTCCTACGGGGG AAAGATTT ATGAAGCTTCTAGCTTGC TAGA
37.Klebsiella oxytoca produces sour Cray uncle formula bacterium GTTGTTCCCTTGAGGA GTGGCTT CATTAAGGTTAATAAC CTTAGTG GCATAACGTCGCAAGA CCAAAGA TAGCACAGAGAGCTTGCT CTCGG
38.Klebsiella pneumoniae kerekou pneumonia uncle formula bacterium GTTGTGCCCTTGAGGC GTGGCT AAGGCGATGAGGTTAA TAACCTCATC CAAAGTGGGGGACCTT CGGGCCTC Same K.oxytoca
Cold gram Lu Wal Salmonella 39.Kluyvera cryocrescens is dwelt Same Kpneumoniae GGCATTAAGGTTAATA ACCTTAGT Same Eaerogenes TAGCACAGAGAGCTTGCT CTTGG
40.Legionela pneumophila legionella pneumophilia TGGTTATATGAAAATA ATTAGT AGGGTTGATAGGTTAA GAGCTGATTAA TGTCTGAGGACGAAAG CTGGGGAC ATGCAAGTCGAACGGCAG CAT
41.Listeria monocytogenes monocyte hyperplasia listeria spp TAGGGGGTTTCCGCCC CTTAGTGC ATAAGAGTAACTGCTT GTCCCTTGAC TGTGGCGCATGCCACG CTTTTGAA ACGGAGGAAGAGCTTGCT CTTCC
42.Moraxella catarrhis morazella catarrhalis AGTTAGGAAGCTTGCT TCTGATA ACCCATAAGCCCTGAC GTTACCCA ATGGCGAAGGCAGCTC CCTGGC TGGGTCTTTTAAAGACTT AGTGAC
43.Mycobacterium avium mycobacterium avium Same Mtuberculosis Same Mtuberculosis CATGTCTTCTGGTGGA AAGCTTTT AAGGCCTCTTCGGAGGTA CTC
44.Mycobacterium bovis Mycobacterium bovis Same Mtuberculosis Same Mtuberculosis TGTCTTGTGGTGGAAA GCGCTTTA AAAGGTCTCTTCGGAGAT ACT
45.Mycobacterium intracellula Mycobacterium intracellulare Same Mtuberculosis Same Mtuberculosis GGACCTTTAGGCGCAT GTCTTTAG GAAAGGCCCCTTCGGGGG TACT
46.Mycobacterium smegmatis M. smegmatics Same Mtuberculosis AGCACAGACGAAGCGC AAGTGA CACCCTGCTGGTCGCA TGGCCTGG AAAGGCCCTTTCGGGGGT ACT
47.Mycobacterium tuberculosis mycobacterium tuberculosis TAGGTGTGGGTTTCCT TCC GGTCCGGGTTCTCTCG GATT GATAGGACCACGGGAT GCATGTCT Same Mbovis
48.Mycobacterium xenopi mycobacterium littorale GTTCTTTCCTGAAGGA TCCGTGCC TTCAGCCTCGACGAAG CTGCG TAGGACCATTCTGCGC ATGTGGG AGGCCCCTTTTTTGGGGT GCT
49.Mycoplasma pneumoniae Mycoplasma pneumoniae GTCGGGGCGATCCCCT CGGTAGTG AATGACTTTAGCAGGT AATGGCTA TTGGTTCGCATGAATC AAAGTT TCGAAAGTAGTAATACTT TA
50.Neisseria gonorrhoeae gonococcus GTCAATTAGCTGTTGG GCAACT AGGCCGTTGCCAATAT CGGCGGCCGAT ACGTCTTGAGAGAGAA AGCAGGGG CACAGGGAAGCTTGCTTC TCG
51.Neisseria meningitidis Neisseria meningitidis GGCAACTTGATTGCTT AGTA GGCTGTTGCTAATATC AGCGGCTGATG ATACGTCTTGAGAGAG AAAGCAGG GCACAGAGAAGCTTGCTT CTC
52.Orientia tsutsugamushi tsutsugamushi fever east body TGGGGGATTTTTCTTT CAGTT TAGTAGGGATGATAAT GACAGTACC TATGCCCTCTATAAGG AGGAAAG AATGCTGAGTTTGCTTAG TATT
53.Pasteurella multocida multocida ATTGGGCTATATGCTT GGTGCCCG GATGTTGTTAAATAGA TGGCATCAT ATCTCTGAGGAGTAAA GGGTGG TAGCAGGAAGAAAGCTTG CTTTC
54.Proteus mirabilis proteus mirabilis ACAGGAGAAAGCTTGC TTTCTTG ACCCTTATCAATTGAC GTTACC CCGGTGGCGAAGGCGG CCCCC TTGTGGTCTTGAACCGTG GCTTCT
55.Pseudomonas aeruginosa Pseudomonas aeruginosa CCGTTGGGATCCTTGA GATC GGGCAGTAAGTTAATA CCTTGCTGT CATACGTCCTGAGGGA GAAAGTG ATGAAGGGAGCTTGCTCC TGGAT
56.Pseudomonas fluorescens Pseudomonas fluorescens CCGTTGGGAGCCTTGA GCTCTT CATTAACCTAATACGT TAGTGTT TACGTCCTACGGGAGA AAGCAG AGAGAGAAGCTTGCTTCT CTTGA
57.Pseudomonas putida pseudomonas putida GCCGTTGGAATCCTTG AGATTT Same Pfluorescens Same Pfluorescens GAGAAGAGCTTGCTCTTC GATTC
58.Pseudomonas stutzeri Pseudomonas stutzeri Same Paeruginosa Same Paeruginosa TCCTACGGGAGAAAGT GGGGGA TGAGTGGAGCTTGCTCCA TGATT
59.Rickettsia prowazekii Rickettsia prowazeki ATCGGAGGATTCTCTT TCGGTTTC ATAATGACGTTACTTG CAGAAAAAG TATTCTCTACGGAGGA AAGATT AACTAGAGCTCGCTTTAG TTAA
60.Rickettsia the vertical rickettsia of rickettsia Same Rprowazekii Same Rprowazekii TATATTCTCTGCGGAG GAA AATTGGGGCTTGCTCCAA TTAG
61.Salmonella paratyphi salmonella paratyphi GGTTGTGCCCTTGAGG CGTGGC Same Styphi TCGCAAGACCAAAGAG GGGGACTT Same Styphimurim
62.Salmonella typhi salmonella typhi Same Sparatyphi TGTTGTGGTTAATAAC CGCAGCAAT Same Styphimurium GAAGCAGCTTGCTGCTTT GCTGA
63.Salmonella typhimurium Salmonella typhimurium Same Sparatyphi Same Styphi AAGACCAAAGAGGGGG ACCTTCGG GAAGCAGCTTGCTCTTTG CTGA
64.Serratia liquefaciens liquid Same Kpneumoniae AGGGTTCAGTGTTAAT AGCACTGTT ATAACGTCTACGGACC AAAGTGGG GAAGCTTGCTCTCTGGGT GACGA
Change Serratia
65.Serratia marcescens serratia marcescens Same Kpneumoniae GGTGGTGAGCTTAATA CGTTCATCA Same Eaerogenes GCACAGGGGAGCTTGCTC CCTGG
66.Serratia plymuthica Plymouth Serratia Same Kpneumoniae GAAGGGCAGTGTGTTA ATAGCACAT Same Sliquefaciens AGCACAGGAGAGCTTGCT CTCTG
67.Serratia rubidaea serratia rubida Same Kpneumoniae AGGAGGAAGGTGGTGA ACTTAATACG Same Eaerogenes GGAGGAAGCTTGCTTCCT CGCCG
68.Shigella boydii Shigella bogdii Same Kpneumoniae AGGGAGTAAAGTTAAT ACCTTTGCTC GAGGGGGACCTTCGGG CCTCTTG CAGGAAGCAGCTTGCTGT TTCGC
69.Shigella dysenteriae shigella dysenteriae Same Kpneumoniae Same Sboydii Same Sboydii CAGAAAGCAGCTTGCTGT TTGC
70.Shigella flexneri shigella flexneri Same Kpneumoniae Same Sboydii Same Sboydii CAGGAAGCAGCTTGCTGT TTCG
71.Shigella Shigellae in Song sonnei Same Kpneumoniae Same Sboydii Same Sboydii CAGGAAACAGCTTGCTGT TTCG
72.Staphylococcus aureus streptococcus aureus TTAGGGGGTTTCCGCC CCTTAGT TAAGTAACTGTGCACA TCTTGACG TATTTTGAACCGCATG GTTCAAAA GGACGAGAAGCTTGCTTC TCTGAT
73.Staphylococcus epidemidis staphylococcus epidermidis Same Saureus AATGTGTAAGTAACTA TGCACGTC TATATTGAACCGCATG GTTCAATA AGACGAGGAGCTTGCTCC TCTGAC
74.Stenotrophomonas maltophilia has a liking for the few food of Fructus Hordei Germinatus Zymomonas mobilis ACAGTAAGAGCTTGCT CTTATG CTCGGTTGTTCTGACG GTACCC CGAAGGCAGCTACCTG GACCAAC GTTGGGTGCAATTTGGCA CGCAGT
75.Streptococcus agalactiae agalasisa TTAGGCCCTTTCCGGG CGTTAGT TAGGAGTGGAAAATCT ACCAAGTG AAGAGTAATTAACACA TGTTAGTT CACCTAGATCCTGATGAG TT
Suis
76.Streptococcus pneumoniae streptococcus pneumoniae GGTGTTAGACCCTTTC CGGGGTC TGTGAGAGTGGAAAGT TCACACTG AAGAGTAGATGTTGCA TGACATTT AAGTAGAACGCTGAAGGA AGGAGC
77.Streptococcus pyogenes streptococcus pyogenes TGTTAGGCCCTTTCCG GGGCTTA GTGGGAGTGGAAAATC CACCAAGT TAAGAGAGACTAACGC ATGTTAGT AACTGGTGCTTGCACCGG TTCAAG
78.Streptococcus salivarium streptococcus-salivarius GTTGGATCCTTTCCGG GATTCAG Same Spneumoniae AATGGATGACCCATGT CATTTATT GAGAGGAGCTTGCTCTTC TTGGAT
79.Yersinia enterocolitica yersinia entero-colitica Same Kpneumoniae AAGGCCAATAACTTAA TACGTTGT CATAACGTCTTCGGAC CAAAGTG AAGTAGTTTACTACTTTG CCGGC
80.Yersinia pestis Yersinia pestis Same Kpneumoniae AAGGGGTTGAGTTTAA TACGCTCAA CATGACCTCGCAAGAG CAAAGTG GGAAGTAGTTTACTACTT TGCC

Claims (2)

1, a kind of biochip is characterized in that this chip is made by following steps:
Utilize the GenBank database, the rrna nucleic acid gene sequence of 80 kinds of bacteriums of retrieval uses Primer Premiere, DNAStar or Clustal-X software to carry out primer, probe design and sequence relatively, synthetic all oligonucleotide sequences that relate to; 16S rRNA universal amplification primer is S1:5 '-AGA GTT TGA TC (A/C) TGG CTC AG-3 ' and S2:5 '-CCG TCA ATT C (A/C) T TT (A/G) AGT TT-3 ', and the amplified fragments size is 890-bp-930-bp; 80 kinds of bacteriums amount to 320 probes, are made up of specification sheets subordinate list 2 described gene orders respectively;
Point sample: will synthesize good probe and dissolve with an amount of 50%DMSO, ultimate density is 2g/l; Biochip is placed GSI Flexys point sample instrument, the point sample program is set, put into the cloth configuration.
2, any biochip as claimed in claim 1 is characterized in that this biochip is used for Bacteria Detection.
CN 03100675 2003-01-21 2003-01-21 Clinical biochip for detecting bacteria Expired - Fee Related CN1232651C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 03100675 CN1232651C (en) 2003-01-21 2003-01-21 Clinical biochip for detecting bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 03100675 CN1232651C (en) 2003-01-21 2003-01-21 Clinical biochip for detecting bacteria

Publications (2)

Publication Number Publication Date
CN1519328A CN1519328A (en) 2004-08-11
CN1232651C true CN1232651C (en) 2005-12-21

Family

ID=34281269

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 03100675 Expired - Fee Related CN1232651C (en) 2003-01-21 2003-01-21 Clinical biochip for detecting bacteria

Country Status (1)

Country Link
CN (1) CN1232651C (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1304599C (en) * 2004-10-21 2007-03-14 复旦大学附属华山医院 Medicine and bacterium resistant detection chip, method for preparation and application thereof
KR101409193B1 (en) * 2005-01-31 2014-06-19 가부시키가이샤 야쿠르트 혼샤 METHOD OF QUANTITATIVELY ANALYZING MICROORGANISM TARGETING rRNA
JP2008118914A (en) * 2006-11-10 2008-05-29 Canon Inc Probe, probe set, probe-immobilized carrier and genetic testing method
AT505849B1 (en) * 2007-09-27 2010-01-15 Wiesinger Mayr Herbert Dipl In METHOD FOR DETERMINING MICROORGANISMS
CN107952149A (en) * 2017-12-20 2018-04-24 陈顺超 One kind operation suction type anaesthetic machine
EP4400604A3 (en) * 2019-03-22 2024-10-16 Gen-Probe Incorporated Compositions and methods for detecting group a streptococcus
CN116219046A (en) * 2023-04-20 2023-06-06 北京纳百生物科技有限公司 Fluorescent quantitative PCR detection kit for E.canis and detection method thereof

Also Published As

Publication number Publication date
CN1519328A (en) 2004-08-11

Similar Documents

Publication Publication Date Title
Fredricks et al. Application of polymerase chain reaction to the diagnosis of infectious diseases
ES2850073T3 (en) Universal 16S ribosomal RNA primers and their use in microbiological analysis and diagnosis
US20130157876A1 (en) Systems and Methods for Detecting Antibiotic Resistance
JP5238248B2 (en) Method for quantitative analysis of microorganisms targeting rRNA
US8632968B2 (en) Method for the detection and/or identification of a microorganism
CN111187804A (en) Rapid detection kit and detection method for mycoplasma pneumoniae nucleic acid based on CRISPR/Cas12a
US20140155283A1 (en) Microarray for detecting viable organisms
CN106661606A (en) Method for detecting and characterising a microorganism
CN101748192B (en) Gene chip of main pathogenic microorganism in drinking water and testing kit
CN114729398A (en) Compositions and methods for rapid identification of bacteria and fungi and phenotypic antimicrobial drug susceptibility testing
BRPI0517131B1 (en) METHODS TO SIMPLIFY MICROBIAL NUCLEIC ACIDS BY CHEMICAL MODIFICATION OF CYTOSINES
Ma et al. A NASBA on microgel-tethered molecular-beacon microarray for real-time microbial molecular diagnostics
CN1232651C (en) Clinical biochip for detecting bacteria
Stefani Diagnostic techniques in bloodstream infections: where are we going?
US20120171681A1 (en) Oligonucleotides, methods and kits for detecting and identifying vancomycin-resistant enterococcus
US9109260B1 (en) Identification of bacteria by amplification and probing
CN110669851A (en) Primer and/or probe composition for detecting cocci causing bloodstream infections and use thereof
CN110656188A (en) Primer and/or probe composition for detecting bacillus causing bloodstream infection and application thereof
WO2021201091A1 (en) Primer set and probe for detecting klebsiella bacteria
CN108271392A (en) The gene resistance prediction of structure change combating microorganisms drug in genome is utilized in microorganism
CN102080127B (en) Gene chip for detecting 15 clinical common pathogenic microorganisms
US20080145845A1 (en) Method and Kit for the Identification and/or Detection and/or Quantification of Large Number of Genes Related to Antibiotic Resistance in (Micro) Organisms
Mandlik et al. Microbial identification in endodontic infections with an emphasis on molecular diagnostic methods: a review
KR101338292B1 (en) Reverse Transcription - Polymerase Chain Reaction - Enzyme-Linked Immunosorbent assay (RT-PCR-ELISA) for Hepatitis A virus
Yang et al. Establishment of portable Pseudomonas aeruginosa detection platform based on one-tube CRISPR/Cas12a combined with recombinase polymerase amplification technology

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee